Atlas Trials

Ranibizumab for Treatment of Persistent Diabetic Neovascularization Assessed by Wide-Field Imaging

Clinical trial NCT00606138 · COMPLETED

Trial details

NCT number
NCT00606138
Sponsor
Rush University Medical Center
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Proliferative Diabetic Retinopathy
Start date
2008-01-01
Primary completion
2010-10-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.